# A Novel Blood Test as a Biomarker in Mental Health

> **NCT06856161** · — · RECRUITING · sponsor: **Fraser Health** · enrollment: 500 (estimated)

## Conditions studied

- Depression - Major Depressive Disorder
- Schizophenia Disorder
- Psychosis
- Mania (Neurotic)
- Alcohol Consumption
- Anxiety Disorder (Panic Disorder or GAD)
- Substance Use Disorders
- Alcohol Use Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06856161
- **Lead sponsor:** Fraser Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-25
- **Primary completion:** 2027-03-15
- **Final completion:** 2027-08-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06856161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06856161, "A Novel Blood Test as a Biomarker in Mental Health". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06856161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*